Pfizer Inc. Ringkasan Perusahaan |
|
Pfizer Inc.(NASDAQ: PFE). The Group's principal activities are to discover, develop, manufacture and market prescription medicines for humans and animals as well as many of the world's best-known consumer products. The Group operates in two business segments pharmaceuticals and consumer products. Pharmaceuticals segment includes prescription pharmaceuticals for treating cardiovascular diseases, infectious diseases, central nervous system disorders, diabetes, erectile dysfunction, allergies, arthritis and other disorders. The major revenue generating pharmaceutical products are Lipitor, Norvasc, Cardura, Accupril, Zithromax, Viracept, Zoloft, Neurontin, Viagra and Zyrtec. Consumer products segment includes consumer health care products, confectionery products, shaving products and tetra fish products. Pharmaceutical products accounted for 84% of 2001 revenues and consumer products, 16%.
|
|
DATA PERUSAHAAN |
 |
Sektor Utama |
Kesehatan & Pharm Umum |
 |
|
Industri Utama |
Healthcare |
|
|
Homepage |
www.pfizer.com |
|
| |
Key Developments: Pfizer Inc.
 |
Laporan Pasar Australia 20 Desember 2010: IMX Resources (ASX:IXR) Meluncurkan Pengapalan Pertama Biji Tembaga Besinya ke Cina
DEC 20, 2010 13:30 - Lihat Artikel: 1,333
Laporan Pasar Australia 20 Desember 2010 memuat: IMX Resources Limited (ASX:IXR) telah meluncurkan pengapalan pertamanya untuk biji tembaga besi ke Cina; Phylogica Limited (ASX:PYC) menanda tangani perjanjian kolaborasi danlisensi dengan Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) menerima hasil yang kuat untuk tembaga, perak, kobalt di Walford Creek, Queensland Baratlaut; Produksi biji besi South American Ferro Metals Limited (ASX:SFZ) di Brazil melampaui 400.000 ton. |
|
25,829 TAMPILAN PROFIL PERUSAHAAN |
|
Halaman ini dilihat: (7 Hari Terakhir: 14) (30 Hari Terakhir: 90) (Sejak Ditampilkan: 1523)
|
|
|
|
